ATE295163T1 - Verwendung von xanthenon-4-essigsäure zur herstellung eines medikaments für die behandlung von hyperproliferativer störungen - Google Patents

Verwendung von xanthenon-4-essigsäure zur herstellung eines medikaments für die behandlung von hyperproliferativer störungen

Info

Publication number
ATE295163T1
ATE295163T1 AT02004592T AT02004592T ATE295163T1 AT E295163 T1 ATE295163 T1 AT E295163T1 AT 02004592 T AT02004592 T AT 02004592T AT 02004592 T AT02004592 T AT 02004592T AT E295163 T1 ATE295163 T1 AT E295163T1
Authority
AT
Austria
Prior art keywords
xanthenone
mammal
acetic acid
hyperproliferative tissue
photodynamic compound
Prior art date
Application number
AT02004592T
Other languages
German (de)
English (en)
Inventor
David A Bellnier
Thomas J Dougherty
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Application granted granted Critical
Publication of ATE295163T1 publication Critical patent/ATE295163T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Radiation-Therapy Devices (AREA)
AT02004592T 2001-03-07 2002-02-28 Verwendung von xanthenon-4-essigsäure zur herstellung eines medikaments für die behandlung von hyperproliferativer störungen ATE295163T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/801,163 US6495585B2 (en) 2001-03-07 2001-03-07 Method for treating hyperproliferative tissue in a mammal

Publications (1)

Publication Number Publication Date
ATE295163T1 true ATE295163T1 (de) 2005-05-15

Family

ID=25180358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02004592T ATE295163T1 (de) 2001-03-07 2002-02-28 Verwendung von xanthenon-4-essigsäure zur herstellung eines medikaments für die behandlung von hyperproliferativer störungen

Country Status (5)

Country Link
US (1) US6495585B2 (cg-RX-API-DMAC7.html)
EP (1) EP1238666B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002325853A (cg-RX-API-DMAC7.html)
AT (1) ATE295163T1 (cg-RX-API-DMAC7.html)
DE (1) DE60204067T2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
JP2002534483A (ja) * 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 代謝性骨障害または骨転移のための治療的組成物
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US20020049247A1 (en) 2000-01-12 2002-04-25 Chen James C. Novel treatment for eye disease
AU2003249742A1 (en) 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
WO2008147445A2 (en) * 2006-11-09 2008-12-04 University Of Maryland, Baltimore Use of 5,6-dimethylxanthenone-4-acetic acid as an antimicrobial agent
US8180444B2 (en) * 2007-06-22 2012-05-15 Biolitec Pharma Marketing Ltd Enhanced PhotoDynamic Therapy with immune system assist
US20110201678A1 (en) * 2008-10-17 2011-08-18 Masse Craig E Xanthenone-4-Acetic Acid Derivatives
CN109289048B (zh) * 2018-08-08 2021-05-25 南京工业大学 一种肿瘤血管阻断协同光治疗试剂及其合成方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
GB9308166D0 (en) * 1993-04-20 1993-06-02 Cancer Res Campaign Tech Cancer therapy

Also Published As

Publication number Publication date
JP2002325853A (ja) 2002-11-12
DE60204067D1 (de) 2005-06-16
EP1238666A3 (en) 2004-01-07
DE60204067T2 (de) 2006-01-26
EP1238666B1 (en) 2005-05-11
EP1238666A2 (en) 2002-09-11
US20020128303A1 (en) 2002-09-12
US6495585B2 (en) 2002-12-17

Similar Documents

Publication Publication Date Title
ATE295163T1 (de) Verwendung von xanthenon-4-essigsäure zur herstellung eines medikaments für die behandlung von hyperproliferativer störungen
ATE497778T1 (de) Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
ATE426405T1 (de) Amino-substituierte diarylaa,ducyclohepten- analoga als muscarinische agonisten und verfahren zur behandlung von neuropsychiatrischen erkrankungen
DE60200774D1 (de) Mikrobizide und algizide Zusammensetzung, mikrobizides und algizides Verfahren für die Behandlung eines Wassersystems und Verfahren, um eine mikrobizide und algizide Zusammensetzung herzustellen
BR0012191A (pt) Processo de redução da concentração de aldeìdo(s) eiou cetona(s) em uma corrente aquosa residual, processo de fabricação de um poliéster ou poliol e processo de fabricação de politrimetileno dicarboxilato
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
DE60144123D1 (de) Verfahren zur Behandlung von Arzneimittelinduzierter peripherer Neuropathie und verwandten Krankheitsformen
ATE492279T1 (de) Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
ATE312809T1 (de) Verfahren zur herstellung von gabapentin
DE602004021358D1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
DE69534620D1 (de) Verfahren zur behandlung von augenerkrankungen
ATE373014T1 (de) Einen nanofiltrationsschritt umfassendes verfahren zur aufreinigung von albumin, lösung und zusammensetzung zur therapeutischen anwendung,die dieses enthalten
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
EP1353669A4 (en) METHOD OF TREATING GLAUCOMA IB
ATE345121T1 (de) Verwendung von konjugierter linolsäure zur behandlung der erkältung
RU2001135372A (ru) Способ лечения длительно незаживающей эрозии и язвы роговицы
ATE508107T1 (de) Verfahren zur herstellung von gabapentin
EP1270000A3 (en) Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
ATE274927T1 (de) Zusammensetzungen enthaltend monoperphthalatsäure zur behandlung von kontaktlinsen
DE602005015870D1 (de) Technik zur Behandlung von Mumien
ATE273244T1 (de) Verfahren zur reduzierung von schadorganismen in wasserströmen
RU2002105337A (ru) Способ лечения задержки психоречевого и интеллектуального развития различного происхождения
EA200400783A1 (ru) Средство для радикального лечения опухолей, воспалительных процессов, грибковых инфекций и других заболеваний тканей, их диагностика и профилактика и метод его применения
ATE418535T1 (de) Verbessertes verfahren zur herstellung von gabapentin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties